S&P 500   4,272.48 (-0.36%)
DOW   33,344.84 (-0.49%)
QQQ   359.21 (+0.26%)
AAPL   173.20 (+1.16%)
MSFT   318.36 (+0.83%)
META   303.71 (+1.17%)
GOOGL   132.97 (+1.61%)
AMZN   128.66 (+1.21%)
TSLA   249.53 (-0.28%)
NVDA   447.20 (+2.81%)
NIO   8.78 (-2.88%)
BABA   86.14 (-0.69%)
AMD   102.87 (+0.05%)
T   14.80 (-1.46%)
F   12.25 (-1.37%)
MU   67.61 (-0.62%)
CGC   0.73 (-6.17%)
GE   108.74 (-1.64%)
DIS   81.23 (+0.22%)
AMC   7.90 (-1.13%)
PFE   33.61 (+1.33%)
PYPL   58.22 (-0.41%)
NFLX   378.40 (+0.21%)
S&P 500   4,272.48 (-0.36%)
DOW   33,344.84 (-0.49%)
QQQ   359.21 (+0.26%)
AAPL   173.20 (+1.16%)
MSFT   318.36 (+0.83%)
META   303.71 (+1.17%)
GOOGL   132.97 (+1.61%)
AMZN   128.66 (+1.21%)
TSLA   249.53 (-0.28%)
NVDA   447.20 (+2.81%)
NIO   8.78 (-2.88%)
BABA   86.14 (-0.69%)
AMD   102.87 (+0.05%)
T   14.80 (-1.46%)
F   12.25 (-1.37%)
MU   67.61 (-0.62%)
CGC   0.73 (-6.17%)
GE   108.74 (-1.64%)
DIS   81.23 (+0.22%)
AMC   7.90 (-1.13%)
PFE   33.61 (+1.33%)
PYPL   58.22 (-0.41%)
NFLX   378.40 (+0.21%)
S&P 500   4,272.48 (-0.36%)
DOW   33,344.84 (-0.49%)
QQQ   359.21 (+0.26%)
AAPL   173.20 (+1.16%)
MSFT   318.36 (+0.83%)
META   303.71 (+1.17%)
GOOGL   132.97 (+1.61%)
AMZN   128.66 (+1.21%)
TSLA   249.53 (-0.28%)
NVDA   447.20 (+2.81%)
NIO   8.78 (-2.88%)
BABA   86.14 (-0.69%)
AMD   102.87 (+0.05%)
T   14.80 (-1.46%)
F   12.25 (-1.37%)
MU   67.61 (-0.62%)
CGC   0.73 (-6.17%)
GE   108.74 (-1.64%)
DIS   81.23 (+0.22%)
AMC   7.90 (-1.13%)
PFE   33.61 (+1.33%)
PYPL   58.22 (-0.41%)
NFLX   378.40 (+0.21%)
S&P 500   4,272.48 (-0.36%)
DOW   33,344.84 (-0.49%)
QQQ   359.21 (+0.26%)
AAPL   173.20 (+1.16%)
MSFT   318.36 (+0.83%)
META   303.71 (+1.17%)
GOOGL   132.97 (+1.61%)
AMZN   128.66 (+1.21%)
TSLA   249.53 (-0.28%)
NVDA   447.20 (+2.81%)
NIO   8.78 (-2.88%)
BABA   86.14 (-0.69%)
AMD   102.87 (+0.05%)
T   14.80 (-1.46%)
F   12.25 (-1.37%)
MU   67.61 (-0.62%)
CGC   0.73 (-6.17%)
GE   108.74 (-1.64%)
DIS   81.23 (+0.22%)
AMC   7.90 (-1.13%)
PFE   33.61 (+1.33%)
PYPL   58.22 (-0.41%)
NFLX   378.40 (+0.21%)
NASDAQ:WVE

Wave Life Sciences (WVE) Price Target & Analyst Ratings

$5.90
+0.15 (+2.61%)
(As of 01:39 PM ET)
Compare
Today's Range
$5.54
▼
$5.99
50-Day Range
$3.87
▼
$5.75
52-Week Range
$3.04
▼
$7.12
Volume
309,765 shs
Average Volume
386,805 shs
Market Capitalization
$583.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Wave Life Sciences Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 7 Analyst Ratings

Consensus Analyst Price Target

$7.00
18.64% Upside
High Prediction$10.00
Average Prediction$7.00
Low Prediction$5.00
TypeCurrent
10/2/22 to 10/2/23		1 Month Ago
9/2/22 to 9/2/23		3 Months Ago
7/4/22 to 7/4/23		1 Year Ago
10/2/21 to 10/2/22
Consensus Rating
Hold
Hold
Hold
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
1 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$7.00$7.00$7.00$8.00
Predicted Upside18.64% Upside64.45% Upside68.92% Upside349.44% Upside
Get Wave Life Sciences Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter.


WVE Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

WVE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Wave Life Sciences Stock vs. The Competition

TypeWave Life SciencesMedical CompaniesS&P 500
Consensus Rating Score
2.43
2.66
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside21.74% Upside605.18% Upside21.71% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/4/2023Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating		J. Schwartz
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingMarket Perform
8/4/2023HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy ➝ Buy$8.00+58.10%
7/5/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageOutperform$7.00+96.63%
5/24/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$13.00 ➝ $10.00+162.47%
5/23/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeBuy ➝ Hold$7.00 ➝ $5.00+31.23%
12/14/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating		M. Foroohar
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetMarket Perform$2.00 ➝ $7.00+46.14%
11/11/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetSector Perform$8.00 ➝ $5.00+19.90%
(Data available from 10/2/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












WVE Price Target - Frequently Asked Questions

What is Wave Life Sciences's consensus rating and price target?

According to the issued ratings of 7 analysts in the last year, the consensus rating for Wave Life Sciences stock is Hold based on the current 4 hold ratings and 3 buy ratings for WVE. The average twelve-month price prediction for Wave Life Sciences is $7.00 with a high price target of $10.00 and a low price target of $5.00. Learn more on WVE's analyst rating history.

Do Wall Street analysts like Wave Life Sciences more than its competitors?

Analysts like Wave Life Sciences less than other Medical companies. The consensus rating for Wave Life Sciences is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how WVE compares to other companies.

Does Wave Life Sciences's stock price have much upside?

According to analysts, Wave Life Sciences's stock has a predicted upside of 64.45% based on their 12-month price targets.

What analysts cover Wave Life Sciences?

Wave Life Sciences has been rated by HC Wainwright, Leerink Partnrs, and Raymond James in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NASDAQ:WVE) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -